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ABSTRACT Custom antibacterial peptides, cecropins B1 (CB1) and B3 (CB3), were synthesized. These peptides have
particular sequence characteristics, with CB1 having two amphipathic -helical segments and CB3 having two hydrophobic
-helical segments. These differences were exploited for a study of their efficacy in breaking up liposomes, which had
different combinations of phosphatidic acid (PA) and phosphatidylcholine (PC), and a study of their lipid binding ability.
Binding and nonbinding lysis actions of CB1 and CB3 on liposomes were examined further by electron spin resonance (ESR).
The spin-labeled lipids 5SL-PC, 7SL-PC, 10SL-PC, 12SL-PC, and 16SL-PC were used as probes. The ESR spectra
revealed larger outer hyperfine splittings (2Amax) for CB1 when the interactions of CB1 and CB3 with liposomes were
compared. These observations indicate a larger restriction of the motion of the spin-labeled chains in the presence of CB1.
Plots of the effective order parameter at the various probe positions (chain flexibility gradient) versus the peptide–lipid ratio
further suggested that the lysis action of CB1 is related to its capacity to bind to the lipid bilayers. In contrast, there is no
evidence of binding for CB3. To augment these findings, four spin-labeled peptides, C8SL-CB1, C32SL-CB1, C5SL-CB3, and
C30SL-CB3, were also examined for their binding to and their state of aggregation within the lipid bilayers. Association
isotherms of the peptides were measured for liposomes containing two molar fractions of PA (0.25 and 0.75). The membrane
binding of the CB1 peptides exhibited a cooperative behavior, whereas the association isotherm of CB3 revealed binding to
the lipid only for  0.75 liposomes. To further identify the location of CB1 in the lipid bilayers, measurements of the collision
rate with chromium oxalate in solution were conducted. Results from ESR power saturation measurements suggested that
the NH2-terminal -helix of CB1 is located on the surface of the lipid bilayers, whereas the COOH-terminal -helix of CB1 is
embedded below the surface of the lipid bilayers. These conclusions were further supported by the observed relationship
between the partition distribution of peptides bound to liposomes at different PA/PC ratios and the amounts of free peptides.
Based on the above observations, possible mechanisms of the bilayer lysis induced by CB1 and CB3 on liposomes of
different composition are discussed.
INTRODUCTION
Cecropins were originally isolated from immune hemo-
lymph of the moth Hyalophora cecropia (Hultmark et al.,
1980; Steiner et al., 1981) and later from other insects
(Boman, 1991; Hultmark, 1993) as agents that kill bacteria.
These antibacterial peptides may also exist in the broader
spectrum of the animal kingdom because a mammalian
cecropin P1 has been isolated from porcine small intestine
(Lee et al., 1989). In addition to their action on bacteria,
cecropins and other antibacterial peptides, such as magain-
ins and their analogs, were found to be able to lyse hema-
topoietic and solid tumor cells with few toxic effects on
normal blood lymphocytes (Jaynes et al., 1989; Cruciani et
al., 1991). These short proteins have, therefore, been re-
ferred to as aBaM.
The sequences of cecropin peptides, which range from 31
to 39 amino acids, are highly conserved with a high pro-
portion of the basic amino acids. The helical conformation
of cecropin A in hexafluoro-2-propanol solution was orig-
inally confirmed by circular dichroism spectroscopy
(Steiner, 1982). Subsequently, its two-dimensional nuclear
magnetic resonance structure was established (Holak et al.,
1988): the peptide folds into two lobes with an NH2-termi-
nal amphipathic helix and a COOH-terminal hydrophobic
helix joined by an Ala-Gly-Pro segment. The maintenance
of the -helical structure of cecropins may be one of the key
factors that enable them to disrupt cell membranes. How-
ever, the details of the correlation between the extent and
stability of the secondary structure of the peptides and their
cell-killing ability remain unknown. Another possible key
factor that may influence membrane lysis is the association
of these peptides with lipid bilayers. This binding effect was
confirmed by evidence of voltage-dependent channel for-
mation by cecropins (Christensen et al., 1988), magainins
(Agawa et al., 1991), and defensins (Kagan et al., 1990;
Cociancich et al., 1993) in lipid bilayers. That membrane
lysis may be through pore formation was further suggested
by the observation that encapsulated ions or other solutes
could be selectively released from lipid bilayer vesicles
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upon the addition of the peptides (Saberwal and Nagaraj,
1994; Boman, 1995; Matsuzaki et al., 1997).
However, the mechanisms by which aBaM peptides
cause cell death are not fully understood yet. It is generally
believed that the peptides associate with the membrane to
form structural domains, which either aggregate and form
pores within the membrane, or cover the membrane with a
detergent-like carpet of molecules, which then destabilizes
the packing of the lipids in the membrane (Pouny et al.,
1992; Merrifield et al., 1994; Gazit et al., 1995). The latter
mechanism was suggested by the high peptide stoichiome-
try required for membrane lysis (Steiner et al., 1988; Pouny
et al., 1992). In contrast, only the initial or final stages of
membrane lysis have been reported to date. The detailed
time course of membrane permeabilization induced by
aBaM peptides remains elusive. Regardless of the killing
pathway, however, it appears that the initial association of
the peptides with the membranes followed by the self-
association of the peptides near the negatively charged lipid
domains may be the key determinants governing the spec-
ificity and effectiveness of the peptides. Extensive studies
on the role of electrostatic interactions in the binding of
cationic peptides to anionic lipid bilayers by theoretical and
experimental approaches have been conducted by the Honig
and McLaughlin groups (Kim et al., 1991; Ben-Tal et al.,
1997a,b). White and coworkers have also demonstrated the
significance of the anionic content of the membrane on the
ability of cationic peptides to induce membrane lysis (Wim-
ley et al., 1994; Hristova et al., 1997).
In earlier work, we have studied the effect of aBaM
peptides on cell membranes by examining the actions of CB
and its analogs, CB1, CB2, and CB3, on liposomes, bacte-
ria, and cancer cells (Chen et al., 1997). The results revealed
that lytic peptides, designed to have extra cationic residues,
were less effective at breaking up liposomes and killing
bacteria, but more effective in lysing cancer cells. CB3
showed no effect on either bacteria or cancer cells. In
addition to the experiments on living cells, we also inves-
tigated the role of membrane composition and the physical
characteristics of the cecropin peptides in liposome lysis
(Wang et al., 1998). The actions of CB, CB1, and CB3 on
membranes consisting of varying ratios of PA and PC were
examined. The results indicated that the higher binding
affinity of CB and CB1 to the polar headgroups of the lipids
was not a precondition for the peptides to be more effective
at lysing lipid bilayers, especially with liposomes of higher
PA contents. Moreover, CB3 showed no binding, or only
weak binding, to liposomes, but its ability to cause dye-
leakage was higher than CB and CB1, if the PA content in
the liposomes was high. Intrinsic and extrinsic stopped-flow
fluorescence measurements further revealed that CB and
CB1 exhibited different kinetic steps in liposomal breakage
from CB3 (Wang et al., 1998). Thus, the lytic pathways
used by CB or CB1 on living cells and liposomes are
different from those used by CB3.
In this report, we augment our earlier observations by
examining the interactions of the cecropin peptides with
lipid bilayers by means of electron spin resonance (ESR)
(Marsh and Watts, 1981; Tanaka and Freed, 1985; Ge and
Freed, 1993). Spin-labeled lipids have been used by Marsh
and coworkers to investigate the insertion of diphtheria
toxin into lipid bilayers (Montich et al., 1995) as well as the
interaction of melittin peptides with neutral and anionic
phospholipid bilayers (Kleinschmidt et al., 1997). They
reported that the binding of melittin to the lipid bilayers
initially caused a restriction of lipid acyl chain motions.
Feix and coworkers have also used the ESR method to study
the binding and the state of aggregation of spin-labeled
cecropin AD in hexafluoro-2-propanol solution (Mchaourab
et al., 1993) and within phospholipid bilayers, and have
proposed a scheme for the interaction between cecropin AD
and membranes (Mchaourab et al., 1994). However, only
one molecule was spin-labeled (lipid or peptide) and only
one kind of peptide was used for these studies. In the present
study, both spin-labeled lipids and spin-labeled peptides are
used in the ESR experiments. We focus on the effects of
CB1, which is characterized by two amphipathic -helices,
and CB3, which has two hydrophobic -helices, on lipo-
somes of different compositions. The basis for the binding
and nonbinding modes of membrane lysis by these peptides
on liposomes of different compositions will be elucidated.
Since the membrane permeabilization induced by CB and
CB1 are similar (Wang et al., 1998), these findings should
bear on the action of CB.
EXPERIMENTAL PROCEDURES
Materials
PC and PA, of 95% and 98% purity, respectively, were purchased from
Sigma Chemical Co. (St. Louis, MO). The product PC is composed by
about 53% unsaturated and 47% saturated PC. Over 95% of PC have the
chain lengths of 16 and 18. DOXYL fatty acid labels was obtained from
Avanti Polar Lipids Inc. (Alabaster, AL). Spin-labeled PCs with the
DOXYL at various positions down the hydrophobic chain of PC (5SL-PC,
7SL-PC, 10SL-PC, 12SL-PC, and 16SL-PC) were then prepared. The
spin-labeled PCs allow the membrane bilayers to be probed at various
depths (see Fig. 1). They were synthesized by condensation of 1-palmitoyl-
2-hydroxy-sn-glycerol-3-phosphocholine and the various DOXYL-labeled
fatty acids. Purity was typically greater than 99% after HPLC purification
(Yin and Hyde, 1989; Dejongh et al., 1990). To spin label the peptides,
MTSSL was purchased from Reanal Chemical Co. (Hungary). MTSSL
reacts very effectively with protein thiol groups to form a disulfide bond,
generating a nitroxide-labeled side chain (Millhauser, 1992; Oh et al.,
1996). Crox was purchased from Aldrich Chemical Co. (Milwaukee, WI).
Sodium chloride was certified to be Fisher grade. Monobasic, monohydrate
sodium phosphate and dibasic, anhydrous sodium phophate were pur-
chased from Sigma. Only deionized and distilled water was used in the
experiments.
Preparation of liposomes
Liposomes, with or without spin-labeled lipids, 4% (w/w), of different
compositions (  PA/(PA  PC)) were prepared in phosphate-buffered
saline (PBS) (10 mM sodium phosphate and 100 mM sodium chloride at
pH 7.4) using the sonication method. A 20-mg mixture of PA and PC (4%
spin-labeled PC), with  varying from 0 to 1, was dissolved in 1 ml
chloroform. After gently shaking to dissolve the solid, the chloroform was
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removed by an argon stream. The lipid was then rehydrated and dispersed
into 2 ml PBS at pH 7.4. The milky solution was sonicated (model G112
SPIT, Laboratory Supplies Co., Hicksville, NY) at 300 W for at least 4 h
until the solution became clear. This procedure typically produces soni-
cated single-bilayer vesicles of the order of 300 Å in diameter. Lipid
concentration was determined by a phospholipid reagent (Wako Pure
Chemical Industries, Tokyo, Japan) using the Barlett assay (Barlett, 1959).
The results were expressed in terms of the concentration of phosphorus.
Stock solutions of spin labeled lipids (10 mM) and unlabeled peptides (2.5
mM) were prepared. For a typical ESR measurement, the total lipid
concentration was fixed at 10 mM and the peptide concentration was varied
to obtain various ratios of peptide/lipid in a total volume of 50 l. The
membrane phase transition of liposomes of different composition was
investigated by using a differential scanning colorimeter. The results show
that the phase transition was not observed in the temperature region used
for the current experiment (25°C) (data not shown).
Preparation of peptides
Custom peptides, C8-CB1, C32-CB1, C5-CB3, and C30-CB3, were syn-
thesized by a 431 peptide synthesizer (Applied Biosystems, Foster City,
CA) as described previously (Chen et al., 1997). The sequences of C8-CB1
and C32-CB1 were derived from CB1, except that the Ile at position 8 or
32 was replaced by Cys. The circular dichroism spectra of CB1, C8-CB1,
and C32-CB1 show that all peptides form secondary structures in the
helix-promoting solvent. More wild-type helical content as compared with
its analogs was obtained (data not shown). Similarly, C5-CB3 and C30-
CB3 were derived from CB3, with the Leu at position 5 or 30 replaced by
Cys (see Fig. 1 for details). The molecular weight (MW) and purity of the
various peptides were determined by mass spectrometry and HPLC. The
results showed that MW/purity are 4107.61/99.0% for C8-CB1, 4106.97/
96.7% for C32-CB1, 3548.79/95.6% for C5-CB3, and 3548.49/95.7% for
C30-CB3. These data agree well with the sequences. The concentration of
the peptide in PBS was determined by the bicinchoninic acid assay (Pierce
Chemical Co., Rockford, IL).
Preparation of spin-labeled peptides
Each of the synthetic peptides, C8-CB1, C32-CB1, C5-CB3, or C30-CB3,
in a degassed, 0.05 M acetate buffer at pH 4.5, was mixed with 5% (v/v)
MTSSL in acetone. The molar ratio of MTSSL/peptide was 5 to 1. The
mixtures were incubated at 25°C for 4 h. The labeled peptides (C8SL-CB1,
C32SL-CB1, C5SL-CB3, or C30SL-CB3) were then separated from the
free spin-label MTSSL by eluting them through Sephadex G-25 using PBS
buffer at pH 7.4. Concentrations of the labeled peptides were determined
by a micro BCA protein assay (Pierce Chemical Co.).
ESR spectroscopy
ESR spectra were recorded with a Varian E-109 X-band spectrometer (Palo
Alto, CA) equipped with an E-231 TE-102 rectangular cavity. Experiments
were done at 25°C maintained to 0.2°C using a nitrogen gas flow
temperature regulation system. The exact temperature was measured with
a thermocouple located at the bottom of the microwave cavity. Samples
were prepared in 1-mm-ID sealed quartz capillaries accommodated within
a standard 4-mm quartz ESR tube. ESR spectra were recorded at the
frequency of 9.518 GHz using a microwave power of 10 mW. The
magnetic field was centered at 3400 G and a field sweep of 100 G was
used. A 100-kHz field modulation was applied with an amplitude of
0.8–1.25 G, depending on the spectral line width.
The ESR spectra of the DOXYL lipid spin label in PA/PC-CB1 and
PA/PC-CB3 mixtures or in PA/PC lipids alone were recorded at constant
temperature and pH. Spectral hyperfine splittings were determined by
fitting the maximum and minimum in the outer wings of the spectrum to a
Gaussian curve. The field difference between the two extremes was then
calculated (see Fig. 2 a). The effective order parameter, Seff, was deter-
mined by
Seff  2Amax 2A2Azz Axx Ayyao/ao, (1)
where 2Amax denotes the maximum outer 14N-hyperfine splitting (see Fig.
2 a); and ao and ao are given by 1⁄3(Amax  2A) and 1⁄3(Axx  Ayy  Azz),
respectively. Axx 5.9 G, Ayy 5.4 G, and Azz 32.9 G, are the principal
values of the 14N-hyperfine coupling tensor of doxylpropane (Jost et al.,
1971). A was obtained by (Gaffney, 1976)
A 1.41 2Amax 2Amin2Azz Axx Ayy Amin, (2)
where 2Amin is the inner 14N-hyperfine splitting (see Fig. 2 a).
In the gel phase of phospholipid bilayer membranes, 2Amax is an
essential parameter to characterize the chain dynamics. In the fluid phase,
FIGURE 1 Amino acid sequences and cartoon structures of the spin-
labeled CB1 and CB3 derivatives and spin-labeled lipids. In C8SL-CB1
and C32SL-CB1, the underlined segments indicate the NH2-terminal and
COOH-terminal amphipathic helices of CB1 with a spin-labeled Cys (C),
respectively. The hinge between the two helices is at Gly23 and Pro24 ().
Both sequences of the spin-labeled CB1 derivatives are identical to those
of CB1 (Wang et al., 1998)), except that Ile8 and Ala32 are replaced by Cys
(C) for C8SL-CB1 and C32SL-CB1, respectively. Similarly, both se-
quences of the spin-labeled CB3 derivatives are identical to that of CB3,
except that Leu5 and Leu30 are replaced by Cys for C5SL-CB3 and
C30SL-CB3, respectively. The structures of the various peptides are indi-
cated by cartoons: amphipathic and hydrophobic helices are represented by
partly shaded and open rectangles, respectively. The location of the spin-
labeled MTSSL in both of the peptides is shown by an arrow. The DOXYL
spin-labeled PC at various positions of the lipid chain is also shown. For
each spin-labeled PC, only the 2-chain is labeled at one of the positions
indicated by the arrow (n  5, 7, 10, 12, 16).
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both 2Amax and Seff can be used as parameters to characterize the chain
mobility at different positions of the probe. We have used these spectral
parameters to compare the bilayer systems with or without CB1 and CB3.
Similar experimental conditions to those used for the spin-labeled lipids
were applied to the study of the spin-labeled peptides. The rotational
correlation time, c, was expressed in terms of the relationship (Keith et al.,
1970),
c 120b 15b 32		Ho1 T20T21 1T201, (3)
where H0 is the strength of the magnetic field; T2(0) and T2(1) are the
transverse relaxation times of mI  0 and mI  1 hyperfine components
(for reference, see Fig. 2 b); b  4
/3 [Azz  1⁄2(Axx  Ayy)]; and 		 
(e/) [gz  1⁄2(gx  gy]. The transverse relaxation time T2(0) was taken
from the linewidth of the ESR spectrum, and the ratio of T2 values was
taken from the relative peak height intensities.
For a spin-labeled peptide in the presence of lipid bilayers, the observed
ESR spectrum often consists of a very sharp component (indicating high
mobility; see F in Fig. 2 b) superimposed on a broader component (indi-
cating lack of mobility; see B in Fig. 2 b). The sharp component corre-
sponds to the free peptides in solution, whereas the broad component
originates from membrane-bound peptides. The height of F at mI  1
could be quantitatively used to determine the fraction of the free-to-bound
peptides in the liposomal solution. The amount of bound peptides was then
calculated by the fraction of the free peptides multiplied by the known
concentration of peptides in the sample (Castle and Hubbell, 1976). Spe-
cifically, the MTSSL spin-labeled peptides at a concentration of 20 M
were titrated with unlabeled liposomes of different compositions. An ESR
spectrum for a known concentration of spin-labeled peptides (Cp) without
lipids was taken and the peak height of the high-field line (h) was recorded.
It is reasonable to assume that the amplitude of the peak height is propor-
tional to the concentration of the free peptides (Keith et al., 1970). Under
the same concentration of spin-labeled peptides with lipids, the peak height
of the high-field line (h) in the ESR spectrum was again measured. The
free peptide concentration, Cf, was determined by Cf  Cp(h/h). The
molar ratio of the associated peptides (b) was then obtained: b  (Cp 
Cf)/Cl, where Cl is the stoichiometric lipid concentration. Plots of b versus
Cf can be used to investigate the binding cooperativity of the peptides to the
lipid bilayers (Schwarz et al., 1986). If this binding isotherm exhibits a
sigmoidal shape, one could obtain a critical peptide concentration, C
f
*, from
the sharp increase in the slope of the curve.
Power saturation of ESR
For the power saturation experiments, samples were loaded into a capillary
fabricated from gas-permeable plastic (Wilmad Glass Co., Inc., Buena,
NJ). Before measurements, oxygen in the sample’s tube was removed by
passing nitrogen around the capillary for at least 20 min. Various concen-
trations of Crox, a relaxing agent (Berg and Nesbitt, 1979; Yager et al.,
1979), were included in the peptide samples. The collisions of Crox with
the spin-labeling probe, namely the nitroxide, result in a Heisenberg
exchange (Molin et al., 1980) and thus broaden its ESR spectrum. The
spin-lattice relaxation rate, 1/T1, for Crox is much faster than that for the
nitroxide. The advantage of using Crox as a relaxer arises from its high
insolubility in the membrane interior, and hence its ability to relax only
nitroxides exposed to the aqueous phase.
Crox was used for two different kinds of measurements. 1) A high
concentration of Crox (50 mM) in peptide solution was used to broaden the
ESR spectrum of nitroxide exposed to the aqueous phase. The change of
signal amplitude at mI  1 with and without Crox should reflect the
extent to which the peptide is free in solution (i.e., unbound) or bound to
the bilayer–aqueous interface but still exposed (see the Results section).
Accordingly, binding and nonbinding peptides to the lipid membrane can
be classified. 2) Different contents of Crox (5, 10, and 25 mM) in peptide
solutions were used to determine the collision rate of the nitroxide with
Crox. The collision rates can be measured by investigating the Heisenberg
exchange rate and the effect on the spectral line shape (Molin et al., 1980).
The observed transverse spin relaxation time is related to the concentration
of Crox as follows (Subczynski and Hyde, 1981):
T2obs1  T201 C
Crox, (4)
where T2 and T20 are the nitroxide transverse spin relaxation times in the
presence and absence of Crox, respectively. The constant of proportional-
ity, C, provides a measure of nitroxide accessibility as well as the collision
rates.
Continuous wave (CW) ESR power saturation can be used to obtain the
half saturation parameter, P1/2, the microwave power required to saturate
the signal to one-half of the amplitude when the spectral line is nonsat-
urated. For a single homogeneous Lorentzian line, the peak-to-peak am-
plitude of the first derivative absorption spectrum, Y, has been derived by
Poole (1983) as follows.
Y KP1/21 P/P1/21.5, (5)
FIGURE 2 Spin-labeled ESR spectra. (a) Typical ESR spectrum of
spin-labeled PC lipid. 2Amax and 2Amin, indicating the maximum (outer)
and the minimum (inner) hyperfine splittings, respectively, are defined. (b)
Typical ESR spectrum of spin-labeled CB1 or CB3 peptide. mI  1,
mI  0, and mI  1 denote the assignment of the three resonance lines
to 14N nuclear spin quantum number. F and B originate from free peptide
(sharp) and peptides bound to lipid bilayer (broad), respectively.
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where K is a proportionality constant and P is the microwave power. The
half saturation parameter in the absence (P1/20 ) and presence (P1/2) of Crox
can be expressed as
P1/2 P1/20  C
Crox. (6)
Again, C is a parameter that reflects the accessibility of the spin label to
the relaxer, Crox; specifically, C is related to C/T20 (see Eq. 4). A plot of
P1/2 versus [Crox] gives the slope, C and the intercept, P1/20 . For each
concentration of Crox, the peak height of the mI  0 line was measured by
gradually increasing the power. P1/2 was obtained by fitting the curve of the
first derivative of the signal amplitude versus the square root of power (for
example, see Fig. 10 a) using Eq. 5. The fitting process was performed
using nonlinear least-square regression.
RESULTS
ESR spectra of spin-labeled lipid chains in the
presence of CB1 and CB3
Lipid chain mobility
The effects of CB1 and CB3 on the lipid chain mobility of
liposomes at the lipid/peptide molar ratio of 500/1 are
shown for various DOXYL spin-labeled lipids, 5SL-PC,
7SL-PC, 10SL-PC, 12SL-PC, and 16SL-PC in Fig. 3.
Liposomes of two different lipid compositions were studied:
  0.25 and   0.75. Panels a and b compare the ESR
spectra of the spin-labeled probes at 25°C in the presence
(solid lines) and absence (dotted lines) of CB1 and CB3
peptides, respectively.
Broader resonances and larger splittings of the spectra are
observed for all spin-labeled liposomes in the presence of
CB1 than those observed for CB3-liposome solutions and
lipid alone, except in the case of 16SL-PC, where all
peptides exhibited similar spectra. Table 1 summarizes the
measured values of 2Amax of different spin-labeled lipids in
  0.25 and   0.75 liposomes in the presence of CB1
and CB3. The biggest perturbation of lipid mobility at  
0.25, upon adding CB1 and CB3, is at the 10 position of
PC, with 	2Amax of 1.4 and 0.8 Gauss, respectively. For
  0.75 liposomes, the largest perturbation by CB1 also
occurs at the 10 position of PC with 	2Amax of 4.1 Gauss.
Thus, a large increase in the maximum outer hyperfine
splittings, 2Amax, of the DOXYL spin label in   0.75
liposomes relative to those in   0.25 liposomes was seen
on CB1 binding. In the case of CB3, the 7 and 12 positions
FIGURE 3 Effect of CB1 or CB3
peptides on the spectra of spin-labeled
lipids. Spectra of the DOXYL lipid
spin-label with the label at a various
positions along the acyl chain of PC
(5, 7, 10, 12, and 16) in (a)  
0.25 liposomes, and (b)   0.75
liposomes. Solid line: spectra ob-
tained with the addition of peptides;
dashed line: control without peptides.
The field scan width is 100 Gauss.
The temperature of the samples was
maintained at 25°C.
TABLE 1 The maximum outer hyperfine splitting (2Amax,
Gauss) observed for the various spin-labeled lipids at
different positions along the acyl chain in the absence and
presence of CB1 and CB3 peptides in PA/PC liposomes of
composition   0.25 and 0.75*
Lipid
Alone CB1 	2Amax CB3 	2Amax
  0.25
5-PCSL 26.3 26.7 0.4 26.2 0.1
7-PCSL 25.0 25.8 0.8 24.9 0.1
10-PCSL 21.8 23.2 1.4 22.6 0.8
12-PCSL 19.7 19.6 0.1 19.2 0.5
16-PCSL 16.4 16.1 0.3 16.3 0.1
  0.75
5-PCSL 25.8 28.6 2.8 25.9 0.1
7-PCSL 24.6 27.3 2.7 25.6 1.0
10-PCSL 22.1 26.2 4.1 22.0 0.1
12-PCSL 19.0 23.0 4.0 20.0 1.0
16-PCSL 16.6 16.5 0.1 16.4 0.2
*  (PA)/(PC  PA) molar fraction.
The value of 	2Amax in each entry corresponds to the difference of 2Amax
between CB1 or CB3 and lipid alone. The peptide and lipid concentrations
used in these experiments were 20 M and 0.1 mM, respectively. All
spectra were recorded at room temperature.
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of PC showed the largest changes (	2Amax 1.0 Gauss) for
  0.75. However, the extent of perturbation on lipid
bilayers induced by CB1 is much higher than that by CB3
(	2Amax  0.60 Gauss, on average, for CB1, and 0.32
Gauss for CB3 at   0.25; and 	2Amax  2.74 Gauss, on
average, for CB1 and only 0.48 Gauss for CB3 at  0.75).
Accordingly, we conclude that there is a restriction of the
motion of the spin-labeled chains in the presence of CB1,
whereas the effect of the binding CB3 on lipid chain mo-
bility was not significant.
Figure 4, a and b, shows plots of Seff versus nSL-PC
(n  2, 7, 10, 12, and 16) for liposomes at   0.25 and
  0.75, respectively. As expected, the calculated Seff
decreases with the nitroxide position, n, as the position of
the nitroxide probe in the lipid chain becomes further re-
moved from the polar head. A similar dependence of 2Amax
was also observed (see Table 1). These results are consistent
with increased immobilization of hydrocarbon chains near
the polar headgroups than toward the tail. In fact, the
segmental flexibility at position 16 is identical for all
peptides. The Seff of the spin probe in the presence of CB1
is otherwise larger than in the case of CB3 over the bulk of
the acyl chain for both lipid compositions studied. It is
interesting to note that the steepest change in the flexibility
gradient is shifted toward the bilayer interior from positions
10 to 12 of the sn-2 acyl chain in  0.75 liposomes upon
binding CB1 (see Fig. 4 b), suggesting an overall stiffening
of the bilayer under these conditions.
Bilayer binding affinities of CB1 and CB3
The spin-labeled lipids exhibiting the largest 	2Amax
(10SL-PC for CB1/CB3 at   0.25 and CB1 at   0.75;
7SL-PC for CB3 at   0.75; see Table 1) were selected
for further study of the relationship between 2Amax and the
molar ratio of peptide/lipid. Figure 5, a and b, shows the
influence of CB1 and CB3, respectively, at different pep-
tide/lipid ratios, on the spin-labeled liposomes for   0.25
and   0.75. These results showed that the degree of
motional averaging decreases dramatically (2Amax in-
creases) when more CB1 is added into the bilayer mem-
brane (see Fig. 5 a). The amount of CB1 needed to saturate
the 2Amax response of DOXYL in the lipid bilayers (CB1/
lipid; mol/mol) is lower at   0.25 (0.1 mol/mol) than at
  0.75 (0.25 mol/mol). However, the perturbation am-
plitude (	2Amax) is smaller with CB1 at   0.25 (1.91
Guass from 0 to 0.1 mol/mol) than at   0.75 (5.5 Gauss
from 0 to 0.25 mol/mol). As a measure of the binding
stochiometry at saturation, we have taken the intercept of
the initial slope in 2Amax with the plateau value shown in
Fig. 5. The lipid/peptide molar ratios are approximately 17
and 7 lipids per CB1, respectively, for liposomes at  
0.25 and   0.75. In contrast, the perturbation of lipid
mobility of the bilayer membranes was not dramatically
affected by the association of CB3 (see Fig. 5 b). The
perturbation amplitudes (	2Amax) are significantly smaller,
by a factor of 2 or 4, than in the case of CB1. Clearly, the
association of CB3 with lipid bilayers, unlike CB1, is weak.
Interactions of MTSSL spin-labeled CB1 and CB3
with lipid bilayers
Binding of peptides to lipid bilayers
Typical ESR spectra of MTSSL spin-labeled peptides,
C8SL-CB1, C32SL-CB1, C5SL-CB3, and C30SL-CB3 in
PBS are shown in Fig. 6 a, (1)-(4), respectively. Three sharp
peaks were observed for all labeled peptides. This observa-
tion indicates that the peptides undergo very rapid and
independent motions of their individual segments. Fig. 6 b
shows the corresponding ESR spectra of the spin-labeled
peptides upon the addition of   0.25 liposomes. The
mobility of C8SL-CB1 and C32SL-CB1 either in aqueous
FIGURE 4 Effective order parameters as a function of the nitroxide
position. The Seff for the various nSL-PC was calculated using Eq. 1
shown in the text. The dependence of Seff on the positions of the DOXYL
lipid spin-label along the chain of the nSL-PC is shown in (a) for  0.25
liposomes and (b) for   0.75 liposomes for the various peptides: CB1
(open circles); CB3 (filled circles); and lipid control (open squares). All
experiments were undertaken at 25°C.
Hung et al. Electron Spin Resonance Study on Phospholipid Bilayers by Antibacterial Peptides 3125
solution or in the solution with liposome could correlate to
1/c (Eq. 3). For free-bound peptides (bound state of Fig. 6,
a or b), c estimated from F component is similar (0.5 ns)
for both C8SL-CB1 and C32SL-CB1. However, c for lipid-
bound C8SL-CB1 and C32SL-CB1, shown in Fig. 6 d are
different (1.5 and 1.8 ns, respectively). The longer c
implies a lower mobility. The issue of forming a secondary
structure of peptides on the change of ESR spectrum may
not be significant in this experiment. It was observed that
the ESR spectra of panels a (unfolded) and b (folded) for
C30SL-CB3 are almost identical. Changes of ESR could
therefore be due to other factors such as characteristics of
the helix, bound state, etc. The residual spectrum shown in
Fig. 6 c(4), is not clear. It may be due to the complex
aggregation between CB3 and lipids.
In this experiment, the ratio of lipid to peptide is 100 to
1, which is far greater than the lipid/peptide binding stoi-
chiometry (17 to 1, see Fig. 5 a). For the MTSSL spin-
labeled CB1 derivatives, C8SL-CB1 (Fig. 6 b(1) and
C32SL-CB1 (Fig. 6 b(2)), each spectrum is a composite of
different subspectra arising from a population of peptides
with different rotational mobility. The sharp component, F,
shown in Fig. 6 b, (1) and (2) is smaller compared with that
shown in Fig. 6 a, (1) and (2). This indicates that the amount
of free peptides in solution has been reduced significantly in
the presence of the liposomes. Clearly, the remaining broad-
ened peaks arise from the peptides bound to the lipid mem-
brane. Finally, the lower amplitudes of the high-field lines
of C32SL-CB1 (Fig. 6 b(2)) when compared with those of
C8SL-CB1 (Fig. 6 b(1) suggest that the COOH-terminal
helix is more immobilized, or binds more tightly to the
lipids than does the NH2-terminal helix. This result indicates
that the COOH-terminal helix may be buried within the inside
of the lipid bilayers. In contrast, the spectra of MTSSL spin-
labeled CB3 derivatives, C5SL-CB3 (Fig. 6 b(3) and C30SL-
CB3 (Fig. 6 b(4), are similar to that of the free peptides (see
Fig. 6 a, (3) and (4)). Again, these results may be taken as
evidence that CB3 binds only marginally to the lipid bilayer.
To determine whether the individual labeled peptides are
buried within the membrane or are physically adsorbed at
the aqueous–membrane interface, 50 mM Crox was added
to the peptide–liposome solutions. Crox is a hydrophilic
paramagnetic compound that collides effectively with the
nitroxide and causes relaxation of the nitroxide electron
spin. A mixture of Crox with MTSSL has been demon-
strated to accelerate electron relaxation and broaden the
ESR spectrum of the nitroxide. The charged Crox cannot
diffuse into the hydrophobic region of the bilayer, and,
therefore, this relaxation broadening could be used to probe
the details of the mode of binding of the various peptides to
the membrane. Fig. 6 d, (1) to (4), show the ESR spectra of
Crox with the spin-labeled peptides, C8SL-CB1, C32SL-
CB1, C5SL-CB3, and C30SL-CB3, respectively, in the
presence of liposomes. As control, the ESR spectra of the
corresponding spin-labeled peptides in the presence of Crox
alone are shown in Fig. 6 c. A comparison between the data
summarized in Fig. 6 c, (1) and (2) and 6 d, (1) and (2),
clearly indicates that some CB1 is buried into the hydro-
phobic region of the membrane, because relatively broad res-
onances are observed for the spin-labeled peptide in the pres-
ence of liposome (see Fig. 6 d, (1) and (2). In contrast, for the
MTSSL spin-labeled CB3 derivatives, the ESR signals of the
corresponding nitroxides are essentially identical in the ab-
sence (see Fig. 6 c, (3) and (4) and presence (see Fig. 6 d, (3)
and (4) of liposomes, both in terms of signal intensity and
spectral widths. These observations indicate that both C5SL-
CB3 and C30SL-CB3 were preferentially partitioned in the
aqueous solution ( 0.25). However, the partitioning of CB3
peptides is membrane-composition dependent. For   0.75
and   1.0 liposomes, we have obtained ESR spectra that
FIGURE 5 Dependence of the maximum outer hyperfine splittings on
the molar ratio of peptides to lipid. (a) 2Amax of 10SL-PC as a function of
the molar ratio of CB1/lipids in   0.25 liposomes (filled circles); and in
  0.75 liposomes (open circles). (b) 2Amax of 10SL-PC as a function of
the molar ratio of CB3/lipids in   0.25 liposome (filled circles); and
2Amax of 7SL-PC as a function of the molar ratio of CB3/lipids in  
0.75 liposome (open circles).
3126 Biophysical Journal Volume 77 December 1999
suggest that C5SL-CB3 may also insert into the hydrophobic
core of the lipid bilayers (data not shown).
Binding affinity of peptides to lipid bilayers
Figure 7, a and b, depicts the amount of spin-labeled CB1
and CB3 (b) bound to liposomes of varying s. C8SL-CB1
and C32SL-CB1 peptides display exponential increases in
the amount of bound peptides when the PA content in the
liposomes is increased (Fig. 7 a). For the MTSSL-labeled
CB3 derivatives, C5SL-CB3 and C30SL-CB3, the results
are significantly different (Fig. 7 b). The data suggest that
the COOH-terminal helix of C30SL-CB3, where the spin
label is located, does not seem to bind at all to the lipid
bilayer, even when the liposomes contain an unusually high
content of PA. In contrast, the NH2-terminal helix in C5SL-
CB3, where the spin label is located in this derivative,
exhibits two stages of binding to the lipid bilayer: below
  0.2, the number of bound peptides reduces as the
content of PA in liposomes increases; above   0.2, the
amount of CB3 bound to the lipids increases linearly as
more PA is incorporated into the liposomes. For the view of
the overall peptide, a slower tumbling upon the binding of
peptides with lipid bilayers may be foreseen.
Binding isotherms of peptides to lipid bilayers
To characterize the binding affinity of the peptides to lipid
membranes, the MTSSL-labeled CB1 and CB3 derivatives
(at a concentration of 20 M) were titrated with varying
concentrations of   0.25 and   0.75 liposomes (the
initial concentration was 10 mM). The molar ratio of the
bound peptides to the lipid bilayers (b) was determined
based on the amplitude of the high-field resonance of the
spectra of the spin-labeled peptides at each concentration of
the lipids. The binding isotherms were analyzed in terms of a
partition equilibrium. Schwarz et al. (1986) reported that the
shape of a binding isotherm of a peptide can provide informa-
tion on the cooperativity of binding to the lipid bilayer.
Plots of the molar ratio, b, of the bound peptides versus
the free peptide concentration (Cf) for C8SL-CB1, C32SL-
CB1, C5SL-CB3, and C30SL-CB3, at   0.25 and  
0.75 liposomes are shown in Fig. 8, a–d, respectively. For
spin-labeled CB1 derivatives, C8SL-CB1 (Fig. 8 a) and
C32SL-CB1 (Fig. 8 b), the binding isotherms reveal sigmoi-
dal shapes, implying positive cooperativity. The effect is
more significant in   0.75 liposomes than in   0.25
liposomes for both C8SL-CB1 and C32SL-CB1. A higher
plateau of b in   0.75 liposomes was also obtained for
both spin-labeled CB1 peptides. This indicates a stronger
affinity of CB1 to the lipids as the amount of the negatively
charged lipids is increased. Also, the b of C8SL-CB1 for
either   0.75 or   0.25 liposomes (Fig. 8 a) is higher
than that of C32SL-CB1 (Fig. 8 b). This observation would
seem to suggest that the COOH-terminal helix penetrates
into the hydrophobic core of the membrane and MTSSL-
labeling at Cys32 interferes somewhat with this binding.
Presumably, the NH2-terminal helix of the CB1 rests on the
membrane–aqueous interface.
For the binding of CB3 to lipids, the results are different.
Only one sigmoidal binding isotherm was observed for
C5SL-CB3 in  0.75 liposomes (Fig. 8 c). The remaining
FIGURE 6 ESR spectra of spin-labeled peptides. (1), C8SL-CB1; (2), C32SL-CB1; (3), C5SL-CB3; and (4), C30SL-CB3 in (a) aqueous solution; (b)
  0.25 liposomes; (c) 50 mM Crox; and (d)   0.25 liposomes and 50 mM Crox.
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binding isotherms, including those for C5SL-CB3 in  
0.25 liposomes (Fig. 8 c) and C30SL-CB3 in both   0.25
and   0.75 liposomes (Fig. 8 d), indicate negligible
binding of the peptides-to-lipid bilayers.
The apparent critical aqueous concentration, Cf*, offers a
measure of the amount of free peptide in equilibrium with a
saturated monolayer of membrane-bound peptide. This
quantity can be inferred from the sigmoidal curves depicted
in Fig. 8, a–c: 15 M and 8 M for C8SL-CB1 in  0.25
and   0.75 liposomes, respectively; and 11 M and 12
M for C32SL-CB1 in   0.25 and   0.75 liposomes,
respectively. Thus, for C8SL-CB1, Cf* is reduced from 15
M to 8 M as the PA content is increased from (  0.25
to   0.75). In other words, C8SL-CB1 shows a stronger
affinity for PA compared to PC. In contrast, the Cf* of
C32SL-CB1 remains almost unchanged for both   0.25
and   0.75 liposomes. However, because Cf* for a given
membrane composition must be the same for a given unla-
beled peptide, the apparent disparity must reflect subtle
effects arising from the perturbation of physical chemistry
of the interaction between the COOH-terminal helix and the
membrane introduced by the bulky nitroxide probe.
Aggregation state of bound peptides
To ascertain whether the observed cooperativity in the bind-
ing is due to aggregation of the peptides within the mem-
brane, ESR experiments were performed on the peptides
bound to acidic liposomes (  1.0) at two peptide/lipid
ratios, 1/50 and 1/10. The peptide solution at the higher
concentration (peptide/lipid ratio of 1/10) was prepared by
adding appropriate amounts of unlabeled CB1 or CB3 de-
rivatives to the 1/50 spin-labeled peptide/lipid solution. The
use of unlabeled peptides to enhance the peptide concentra-
tion obviates any effects on the broadening of the ESR line
widths from spin–spin interactions, which might otherwise
occur when labeled peptide is used. If the peptides are
aggregated in the membrane, the line widths of the ESR
spectra may become broader because of a reduction in the
rotational correlation time of the aggregated peptides (Ar-
cher et al., 1991). Figure 9, a–c, compares the results of
MTSSL-labeled peptides, C8SL-CB1, C32SL-CB1, and
C5SL-CB3, respectively, at peptide/lipid ratios of 1/50
(curves i) and 1/10 (curves ii) in 1 mM liposomes of  1.0
and 50 mM Crox (to eliminate the ESR signals arising from
free and unbound peptide). Despite the difference in signal
intensity of the spectrum of C8SL-CB1 between (i) and (ii)
in Fig. 9 a, the spectral line shapes are virtually identical,
i.e., the line width does not depend on the amount of
peptides in the bilayer. Although this result might imply that
CB1 does not aggregate in the membrane, we prefer to
interpret these data to mean that the local motions of the
nitroxide spin label are relatively insensitive to the state or
details of aggregation of the peptides within the membrane.
Similar results have been obtained for C32SL-CB1 and
C5SL-CB3 peptides: here, the intensity and line widths of
the spectra shown for both peptide/lipid ratios are almost
identical (compare Fig. 9, b and c, respectively).
Accessibility of the bound peptides to aqueous solution
The interaction of Crox with nitroxide was investigated
using the method of CW ESR power saturation. Peptide–
liposome (  0.25) complexes were titrated with Crox at
different concentrations.
To ensure that Crox relaxes only the membrane-bound
spin label, two approaches were conducted: 1) High con-
centration of lipid (4 mM) was used to increase the amount
of membrane-bound peptides, i.e., to decrease the amount of
peptides free in solution, and 2) High concentration of Crox
(5–15 mM) were used to remove any interference due to the
peptides free in the aqueous phase. A relatively broad spec-
FIGURE 7 Binding affinity of the associated peptides with the PA
content in the liposome. The molar ratio (b) of the associated peptides to
the lipid was measured as a function of . (a) C8SL-CB1 (filled circles)
and C32SL-CB1 (open circles); (b) C5SL-CB3 (filled circles) and C30SL-
CB3 (open circles). The experiments were conducted on samples contain-
ing 20 M spin-labeled peptides and 2 mM nonspin-labeled lipids.
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trum originated from membrane-bound peptides was shown
(see inset of Fig. 10 a). A typical plot of the first derivative
of the signal amplitude versus the square root of power for
C32SL-CB1 is shown in Fig. 10 a. Based on the best fit
(solid lines in Fig. 10 a), P1/2 at different conditions were
obtained. Plots of P1/2 as a function of [Crox] for both
C8SL-CB1 and C32SL-CB1 are shown in Fig. 10 b. The
slopes, C, 24.9 mW/mM for C8SL-CB1 and 6.43 mW/mM
for C32SL-CB1, reflect the relative measure of nitroxide
accessibility to the aqueous phase (Eq. 6). It is evident that
the effect of Crox on P1/2 is larger for a nitroxide at the C8
residue of CB1 than for that at the C32 residue.
DISCUSSION
Perturbations of the lipid bilayer by peptides
The binding of CB1 to lipid bilayers causes a restriction of
the lipid acyl chain motion as revealed by spectral broad-
ening and increases in 2Amax. The 2Amax reaches a plateau
FIGURE 8 Equilibrium concentration of the associated peptides with the free peptide concentration. The molar ratio (b) of the associated peptides to
lipids (mmol to mol) is plotted as a function of the free peptide concentration (Cf) at equilibrium. (a) C8SL-CB1 at   0.25 (filled circles) and   0.75
liposomes (open circles); (b) C32SL-CB1 with  0.25 (filled circles) and  0.75 liposomes (open circles); (c) C5SL-CB3 with  0.25 (filled circles)
and   0.75 liposomes (open circles), and (d) C30SL-CB3 with   0.25 (filled circles) and   0.75 liposomes (open circles). The total concentration
of spin-labeled peptides was 20 M in each of these experiments.
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maximum at a peptide concentration that reflects the bind-
ing stoichiometry of the particular lipid-type for CB1 (Fig.
5 a). The plateau is reached at a lower bound peptide
concentration for   0.25 liposomes than for   0.75
liposomes. In terms of binding stoichiometry, the plateau
level corresponds to a molar lipid/peptide of 17 lipids per
CB1 for   0.25 liposomes and 7 lipids per CB1 for  
0.75 liposomes. These results most likely reflect the differ-
ent capacity for binding CB1 for the two types of liposomes
(different level of negative charge). However, differences
arising from the membrane fluidity between the two lipo-
somes cannot be ruled out.
For comparison, Kleinschmidt et al. (1997) reported
lipid/peptide molar ratio of approximately 60 and 10 for the
DMPC/melittin and DTPG/melittin complexes, respec-
tively. Our earlier biosensor results (Wang et al., 1998) also
indicated a stronger binding of CB1 to more acidic lipids
(Ka  3.04  104 M1s1 for   0.75 liposomes and
Ka  1.52  104 M1s1 for   0.25 liposomes). These
results would seem to suggest that there is an electrostatic
enhancement of peptide binding to lipid bilayers with a
FIGURE 9 ESR spectra of spin-labeled peptides at different peptide/
lipid ratios. The ESR spectra of the peptide-liposome dispersions at dif-
ferent peptide/lipid ratios of 1/50 and 1/10. The liposomes used in this
experiment consist of 100% PA and the concentration of lipid is 1 mM. (a)
20 M C8SL-CB1 and 50 mM Crox (curve i), and 20 M C8SL-CB1 plus
80 M C8-CB1 and 50 mM Crox (curve ii). (b) 20 M C32SL-CB1 and
50 mM Crox (curve i), and 20 M C32SL-CB1 plus 80 M C32-CB1 and
50 mM Crox (curve ii). (c) 20 M C5SL-CB3 and 50 mM Crox (curve i),
and 20 M C5SL-CB3 plus 80 M C5-CB3 and 50 mM Crox (curve ii).
FIGURE 10 ESR power saturation of spin-labeled peptides as a function
of Crox. (a) A typical example of the first derivative of the ESR signal
amplitude (A) versus the square root of microwave power (P1/2) for
C32SL-CB1 at  0.25. (b) Plots of P1/2 versus the [Crox] for C8SL-CB1
and C32SL-CB1. The concentrations of spin-labeled peptides and non-
spin-labeled lipids used for this experiment were 20 M and 4 mM,
respectively.
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higher anionic content for both CB1 and melittin (Terwill-
iger and Eisenberg, 1982), which have amphipathic -heli-
ces. The stronger binding of peptides to the lipid headgroups
may translate into greater motional restriction when the
peptides bind to the lipid membranes (Wang et al., 1998).
In the case of CB3, with two hydrophobic -helices and
a net positive charge of 3, the binding interactions with the
lipid bilayers are clearly different. Unlike CB1, which
shows a clear trend in its interaction with lipids, CB3 shows
only a weaker interaction with both   0.25 and   0.75
lipid bilayers (Fig. 5). Moreover, the data obtained for CB3
showed an irregular pattern. These observations support the
suggestion that CB3 peptides cluster in the domains of the
membrane enriched in lipid with neutral headgroups,
namely, PC (Wang et al., 1998). The amplitude of the
perturbation of lipid chain mobility (	2Amax) caused by
CB3 is much smaller than that of CB1 (Table 1). We
surmise that the lysis action induced by CB3 is different
from that of CB1 and may not involve electrostatic binding
with the anionic lipid in the bilayer.
Binding of CB1 and CB3 to lipid bilayers
To further understand the membrane binding of the peptides
and their distributions in phospholipid bilayers, both CB1
and CB3 were spin-labeled at different positions, and their
binding were examined. The results obtained suggest that
the binding of spin-labeled CB1 to phospholipid bilayers is
mediated to a large extent by electrostatic interactions. In
  0.25 liposomes, the NH2-terminal -helix of CB1 may
be parallel to the lipid bilayers (Fig. 6, (1)a–(1)d). From the
power saturation study of spin-labeled CB1, we found that
C8SL-CB1 is relaxed more easily by Crox than is C32SL-
CB1 (Fig. 10 b). This latter observation suggests that the C8
residue resides near the membrane–aqueous interface, while
C32 is embedded in the membrane. Altenbach et al. (1989)
have applied this method to define the details of insertion
spin-labeled bacteriorhodopsin into membrane. In the latter
experiments, the spin label is attached to a transmembrane
segment, so the accessibility to Crox should be limited and
the change of P1/2 in the presence of 50 mM Crox was not
found to be significant. However, with our present system,
significant changes in the P1/2 were observed even though
only 0.25 mM of Crox was used. Our results on CB1
provide clear evidence that the nitroxide on the two peptide
derivatives studied here are at least partially accessible to
water.
Mchaourab et al. (1994) have offered a schematic illus-
tration of the cecropin AD-lipid bilayer (POPC and POPG)
interaction in which the COOH-terminal -helix is inserted
into the hydrophobic core. In the case of   0.25 lipo-
somes, our results agree well with this proposal (Fig. 8 b).
The higher propensity toward dye-leakage in   0.25
liposomes in the presence of CB1 (Wang et al., 1998) may
be caused by the aggregation of these peptides to form a
pore (Fig. 9), which might lead to the liposome disruption.
In the case of   0.75 liposomes, although we have also
observed the insertion of the COOH-terminal -helix of
CB1 into the liposomes, as for CB1 in   0.25 liposomes
(albeit to a less extent), the orientation of the overall peptide
in the bilayer membrane may be different. Here, the lipid
packing associated with a membrane containing a high
concentration of PA might be tighter, and the COOH-
terminal -helix may have less tendency to insert into the
bilayer membrane. In any case, we expect stronger interac-
tion of the NH2-terminal -helix of CB1 with the more
anionic PA lipids on the surface of  0.75 liposomes (Fig.
8 a). Both considerations would retard the insertion of the
COOH-terminal -helix into the lipid bilayer. This predic-
tion agrees well with our earlier membrane permeability
studies (Wang et al., 1998), which showed a weaker dye-
leakage activity for CB1 when  is increased to 0.75 or
higher.
For CB3, the interaction with the membrane is very
different. Based on the observations shown in Fig. 8, c and
d, only C5SL-CB3 showed sufficient binding to   0.75
liposomes to manifest itself. This lack of lipid binding, as
revealed by studies on the spin-labeled peptides, was also
noted in the spin-labeled lipid experiments (Fig. 5 b), and is
consistent with the biosensor binding results reported re-
cently from our laboratory (Wang et al., 1998). The asso-
ciation of C5SL-CB3 with lipids is apparently also different
between weakly negatively charged (  0.25) and highly
negatively charged liposomes (  0.75). In the former,
C5SL-CB3 appears to associate with the lipids mainly
through hydrophobic interactions. As the content of PA
lipids is increased, electrostatic interactions involving the
small number of cationic residues in CB3 may be sufficient
to contribute to binding. In Fig. 7 b, a linear relationship is
observed between bound peptide and the increase in the
acidic content of the liposomes for C5SL-CB3. This obser-
vation suggests that the interaction of the NH2-terminal
region of CB3 with the lipids is enhanced by electrostatic
interactions. These results support the notion that the NH2-
terminal -helix of CB3 inserts into the lipid bilayer during
the initial stages of membrane lysis. The higher membrane
lysis activity of CB3 compared with CB1 on   0.75
liposomes observed previously (Wang et al., 1998) may
therefore be interpreted in terms of the stronger binding of
CB3 to the lipid surface. However, more experiments need
to be performed to clarify this point.
SUMMARY
The goal of this study was to correlate the properties of the
CB analogs, CB1 and CB3, which have different character-
istics in their helical segments, to their ability to bind to
membrane lipids and to lyse or disrupt the lipid bilayer
membrane. The present investigations were carried out by
ESR using both spin-labeled lipids and spin-labeled pep-
tides. Based on the results obtained, we have developed a
fairly in-depth picture on how CB1 and CB3 may bind and
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interact with liposomes. To further investigate the detailed
process of membrane lysis, future studies will focus on the
dynamics of membrane permeabilization induced by pep-
tides using kinetic measurements.
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